We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 25, 2020

Anti–PD1-Induced Immune-Related Adverse Events Associated With Survival Outcomes in Advanced Melanoma

The Oncologist


Additional Info

The Oncologist
Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma
Oncologist 2020 Feb 12;[EPub Ahead of Print], A Suo, Y Chan, C Beaulieu, S Kong, WY Cheung, JG Monzon, M Smylie, J Walker, D Morris, T Cheng

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading